Cross-infection with Pseudomonas aeruginosa among cystic fibrosis (CF) patients is a rare occurrence.
pulmonary infection in patients with cystic fibrosis (CF). These infections contribute considerably for morbidity and mortality of CF patients due to an intense host inflammatory response which leads to an irreversible loss of lung function (7) . Many studies indicate that the same CF patients may harbour distinct strains in their respiratory tract, suggesting that may be a relatively high heterogeneity of strains of P. aeruginosa in the CF pulmonary microbiota . It is also known that chronic CF patients are colonized by unique strains, and cross-infection was considered to be rare (11) . More recently, the emergence of transmissible P. aeruginosa has been reported with increasing frequency among unrelated individuals which constitute an emerging threat to patients with CF (3, 5) . The presence of common clones circulating among different CF patients was described in Europe and the United States of America (1, 6). The first major transmissible P. aeruginosa CF strain (Liverpool Epidemic Strain -"LES") was identified in Liverpool -UK (1), where it occasionally "superinfected" individuals and eventually replaced their original strains (6) .
Moreover, the "Midlands 1" strain was originally isolated in UPGMA dendrograms were drawn with a position tolerance of 1.00% and optimization of 1.00%. The following transmissible strains were compared with the clinical isolates: "clone C" (8),
"LES" (1), "Manchester" (2) and "Midlands" (10) 
